OTC · CIK 0001297937
PRKA PARKS AMERICA, INC
Insider trading from SEC Form 4. Last filing Aug 14, 2025. Close $40.11 on Oct 9, 2026, +14% from the 52-week low and -7% from the high.
PARKS AMERICA, INC (PRKA) has 3 SEC Form 4 filings on file from 2 insiders, the latest filed on Aug 14, 2025. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
3 open-market trades have been scored at PRKA. The newest: Jacob Lawrence McDonough (director) bought $125k of stock on Aug 13, 2025, filed Aug 14, 2025, scored 45 (moderate). The largest of the 3 shown: Focused Compounding Fund, LP (10% owner) bought $304k on Feb 14, 2025, scored 21 (weak).
PRKA closed at $40.11 on Oct 9, 2026, 14% above its 52-week low and 7% below its 52-week high.
Last 90 days
Price and insider trades, last year
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at PARKS AMERICA, INC, scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 45Moderate | Jacob Lawrence McDonough director buy | $125k 3,171 shares | +737% | +10268% from low-18% from high | |
| 23Weak | Jacob Lawrence McDonough director buy | $20k 430 shares | - | +12597% from low0% from high | |
| 21Weak | Focused Compounding Fund, LP owner buy | $304k 867,514 shares | +3% | - |
Transactions
Every row filed, 17 in all.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 13, 2025 | Jacob Lawrence McDonough director | POpen-market purchase Common Stock, par value $0.001 per shareindirect: See Footnote | +774 | $39.40 | $30k | 1,204 | Aug 14, 2025 |
| Aug 13, 2025 | Jacob Lawrence McDonough director | POpen-market purchase Common Stock, par value $0.001 per shareindirect: See Footnote | +329 | $38.62 | $13k | 1,533 | Aug 14, 2025 |
| Aug 13, 2025 | Jacob Lawrence McDonough director | POpen-market purchase Common Stock, par value $0.001 per shareindirect: See Footnote | +320 | $34.85 | $11k | 1,853 | Aug 14, 2025 |
| Aug 13, 2025 | Jacob Lawrence McDonough director | POpen-market purchase Common Stock, par value $0.001 per shareindirect: See Footnote | +300 | $38.90 | $12k | 2,153 | Aug 14, 2025 |
| Aug 13, 2025 | Jacob Lawrence McDonough director | POpen-market purchase Common Stock, par value $0.001 per shareindirect: See Footnote | +300 | $39.80 | $12k | 2,453 | Aug 14, 2025 |
| Aug 13, 2025 | Jacob Lawrence McDonough director | POpen-market purchase Common Stock, par value $0.001 per shareindirect: See Footnote | +100 | $38.82 | $3,882 | 2,553 | Aug 14, 2025 |
| Aug 13, 2025 | Jacob Lawrence McDonough director | POpen-market purchase Common Stock, par value $0.001 per shareindirect: See Footnote | +148 | $38.00 | $5,624 | 2,701 | Aug 14, 2025 |
| Aug 14, 2025 | Jacob Lawrence McDonough director | POpen-market purchase Common Stock, par value $0.001 per shareindirect: See Footnote | +100 | $41.00 | $4,100 | 2,801 | Aug 14, 2025 |
| Aug 14, 2025 | Jacob Lawrence McDonough director | POpen-market purchase Common Stock, par value $0.001 per shareindirect: See Footnote | +100 | $40.50 | $4,050 | 2,901 | Aug 14, 2025 |
| Aug 14, 2025 | Jacob Lawrence McDonough director | POpen-market purchase Common Stock, par value $0.001 per shareindirect: See Footnote | +100 | $40.78 | $4,078 | 3,001 | Aug 14, 2025 |
| Aug 14, 2025 | Jacob Lawrence McDonough director | POpen-market purchase Common Stock, par value $0.001 per shareindirect: See Footnote | +100 | $42.92 | $4,292 | 3,101 | Aug 14, 2025 |
| Aug 14, 2025 | Jacob Lawrence McDonough director | POpen-market purchase Common Stock, par value $0.001 per shareindirect: See Footnote | +500 | $42.74 | $21k | 3,601 | Aug 14, 2025 |
| May 16, 2025 | Jacob Lawrence McDonough director | POpen-market purchase Common Stock, par value $0.001 per shareindirect: See Footnote | +55 | $42.00 | $2,310 | 55 | May 16, 2025 |
| May 16, 2025 | Jacob Lawrence McDonough director | POpen-market purchase Common Stock, par value $0.001 per shareindirect: See Footnote | +275 | $47.70 | $13k | 330 | May 16, 2025 |
| May 16, 2025 | Jacob Lawrence McDonough director | POpen-market purchase Common Stock, par value $0.001 per shareindirect: See Footnote | +100 | $48.25 | $4,825 | 430 | May 16, 2025 |
| Feb 14, 2025 | Focused Compounding Fund, LP owner | POpen-market purchase Common Stock, par value $0.001 per shareindirect: See Footnote | +673,928 | $0.35 | $236k | 31,128,633 | Feb 18, 2025 |
| Feb 14, 2025 | Focused Compounding Fund, LP owner | POpen-market purchase Common Stock, par value $0.001 per shareindirect: See Footnote | +193,586 | $0.35 | $68k | 31,322,219 | Feb 18, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- Focused Compounding Fund, LPowner
- Jacob Lawrence McDonoughdirector
Questions about PRKA
Answered from the filings on this page, as of the latest one.
Are insiders buying PRKA?
No. In the last 90 days no insider at PARKS AMERICA, INC bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade PRKA on the open market?
Jacob Lawrence McDonough (director) bought $125k of PRKA on Aug 13, 2025 and filed the Form 4 on Aug 14, 2025. InsiderTell scored 45 (moderate).
How many insiders file Form 4 at PARKS AMERICA, INC?
2 people have filed a Form 4 at PARKS AMERICA, INC, among them Focused Compounding Fund, LP (10% owner), Jacob Lawrence McDonough (director). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.